Share chart CK Life Sciences Int'l., (Holdings) Inc.
About CK Life Sciences Int'l., (Holdings) Inc.
CK Life Sciences Int'l., (Holdings) Inc., инвестиционная холдинговая компания, занимается исследованиями, разработками, производством, коммерциализацией, маркетингом и продажей товаров для здоровья и сельского хозяйства в Азиатско-Тихоокеанском регионе и Северной Америке. more detailsMain settings
IPO date
2002-07-16
ISIN
KYG2176J1058
Industry
Biotechnology
Sector
Health Care
Валюта
hkd
Валюта отчета
hkd
Див.доход ао
2.34
Дивиденд ао
0.008
Сайт
Grade
Underestimation
| Title | Value | Grade |
| P/S | 0.7048 | 10 |
| P/BV | 1.11 | 9 |
| P/E | 339.87 | 1 |
Efficiency
| Title | Value | Grade |
| ROA | -1.15 | 0 |
| ROE | -3.29 | 0 |
| ROIC | 0 | 0 |
Dividends
| Title | Value | Grade |
| Dividend yield | 0 | 0 |
| DSI | 0.7857 | 7.86 |
| Average dividend growth | -2.08 | 0 |
Debt
| Title | Value | Grade |
| Debt/EBITDA | 9.92 | 0 |
| Debt/Ratio | 0.5075 | 9 |
| Debt/Equity | 1.56 | 7 |
Growth impulse
| Title | Value | Grade |
| Yield Revenue, % | 11.74 | 2 |
| Yield Ebitda, % | -69.78 | 0 |
| Yield EPS, % | -231.68 | 0 |
Prices
| Price | Min. | Max. | Change | Changes in the industry | Changes in the index | |
| Yesterday | 0.85 HK$ | 0 HK$ | 0 HK$ | 0 % | 0 % | 0 % |
| Week | 0.9 HK$ | 0.85 HK$ | 0.89 HK$ | -5.56 % | 0 % | 0 % |
| Month | 0.84 HK$ | 0.81 HK$ | 0.92 HK$ | 1.19 % | 0 % | 0 % |
| Three month | 0.77 HK$ | 0.46 HK$ | 1.03 HK$ | 10.39 % | 0 % | 0 % |
| Half a year | 0.49 HK$ | 0.4 HK$ | 1.03 HK$ | 73.47 % | 0 % | 0 % |
| Year | 0.35 HK$ | 0.325 HK$ | 1.03 HK$ | 142.86 % | 0 % | 0 % |
| 3 years | 0.69 HK$ | 0.31 HK$ | 1.03 HK$ | 23.19 % | 0 % | 0 % |
| 5 years | 0.98 HK$ | 0.31 HK$ | 1.22 HK$ | -13.27 % | 0 % | 0 % |
| 10 years | 0 HK$ | 0.31 HK$ | 1.22 HK$ | 0 % | 0 % | 0 % |
| Year to date | 0.5 HK$ | 0.4 HK$ | 1.03 HK$ | 70 % | 0 % | 0 % |
Contained in ETF
ETF | Share, % | Profitability for 1 year, % | Commission, % |
| Loncar China BioPharma ETF | 1.92 | 16603.7 | 0.79 |
| 1.92 | 16,603.7 | 0.79 |
|---|
Similar companies
P/E & P/BV
Company management
| Head | Job title | Payment | Year of birth |
| Mr. Ying Choi Yu | CEO, VP & Executive Director | 14.36M | 1956 (69 years) |
| Dr. Kean Meng Toh | VP, Chief Scientific Officer & Executive Director | 5.84M | 1967 (58 years) |
| Mr. Wun Lam Wong | Chief Financial Officer | N/A | 1965 (60 years) |
| Mr. Pak To Wu | Chief Operating Officer of Global Operations | N/A | 1962 (63 years) |
| Ms. Ching Sze Chiu | General Counsel | N/A | 1977 (48 years) |
| Mr. Tzar Kuoi Li B.Sc., LLD, LLD (Hon), M.Sc. | Executive Chairman | 125k | 1964 (61 year) |
| Mr. Hing Lam Kam B.Sc., B.ScE, M.B.A. | President & Executive Director | 2.85M | 1946 (79 years) |
| Mr. Edmond Tak Chuen IP B.A., M.Sc. | Senior VP, Chief Investment Officer & Executive Director | 1952 (73 years) | |
| Ms. Yau Lin Wong | Senior Manager of Human Resources & Administration | 1967 (58 years) | |
| Ms. Sze Mun Ho | Vice President of Corporate Development | 1972 (53 years) |
About company
Address: Hong Kong, Tai Po, 2 Dai Fu Street - Open in google maps, Open in yandex maps
Website: https://www.ck-lifesciences.com
Website: https://www.ck-lifesciences.com
